Primary Prevention of Hypertension in Obese Adolescents

Completed · Phase 2 · Has a placebo group

Conditions studied: Obesity, Pre-Hypertension, Hyperuricemia

In brief

The purpose of this study is to examine the consequences of lowering serum uric acid in pre-hypertensive, obese adolescents pathways involved with how uric acid mediated hypertension and renal disease. The specific aims are: 1. Test the hypothesis that lowering uric acid will improve endothelial function. 2. Test the hypothesis that lowering uric acid will reduce plasma renin activity and serum angiotensin II levels. 3. Test the hypothesis that lowering uric acid will reduce markers of inflammation

Key facts

Study ID
NCT00288158
Run by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
People needed
60
Starts
2008-09-01
Expected to finish
2011-01-01
Last updated by the study team
2017-09-14

Who can join

Age: 11 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.